Delaware Clinical Trials Report — May 2026

For Delaware residents considering participation in clinical research, May 2026 presents a crucial window, particularly for those looking to join studies that are nearing their enrollment deadlines. Across the state, 26 clinical trials are slated to close within the next 90 days. This urgency extends to healthy volunteers, with 7 of these rapidly closing studies actively seeking participants without specific health conditions. Individuals interested in contributing to medical advancements should explore these options promptly before they are no longer available.

Patients managing certain health conditions also face impending deadlines to join research. Trials focused on various types of cancer, aging-related conditions, and cardiovascular health are among those with limited time remaining for enrollment. Conditions with trials closing soon include:

• Aging
• Breast cancer
• Advanced solid tumor
• Anatomic stage II breast cancer AJCC v8
• Anatomic stage III breast cancer AJCC v8
• Anxiety disorders and symptoms
• Asthma
• Arthritis
• Advanced malignant neoplasm
• Cardiovascular risk factor

These opportunities represent a chance to contribute to the understanding and treatment of these conditions, but time is of the essence for potential participants.

A Closer Look at Delaware's New Research Opportunities

This month, Delaware saw the opening of 1 new clinical trial, a notable decrease compared to the 5 trials that launched in April 2026 and 1 in March 2026. Despite this dip in new openings, the state continues to offer a broad array of research opportunities, with a total of 290 clinical trials currently recruiting across 15 cities and 122 research sites.

The single new trial launched this month focuses on a critical area of patient care and is sponsored by a prominent local institution:

• Christiana Care Health Services is sponsoring NCT07568210, a study titled "Impact of a Tracheostomy Team Implementation on Length of Stay and Unplanned Decannulation." This study aims to enroll 706 participants and evaluate the impact of a specialized tracheostomy team on hospital length of stay (LOS) and unplanned decannulation (UPD) rates in adult tracheostomy patients. This research is vital for improving outcomes and safety for individuals requiring tracheostomies.

This new study is specifically for tracheostomy patients and is located in Newark, making it accessible to residents in that area and surrounding communities. It is an "OTHER" type of study, indicating it may involve quality improvement, observational research, or implementation science rather than a traditional drug or device trial.

Geographic Reach and Participation in Delaware Trials

Delaware's clinical trial landscape, while smaller than some larger states, offers opportunities across a significant portion of its geography. With 290 trials currently recruiting across 15 cities and 122 research sites, residents have various options for participation. The new trial this month is located in Newark, which is a key research hub within the state. Other cities with active trials contribute to the statewide distribution, ensuring that research is not solely concentrated in one metropolitan area.

For individuals without a specific medical condition, there are ongoing opportunities to contribute. While 0 of the new trials this month accept healthy volunteers, there are still 31 total trials statewide that are actively recruiting healthy participants. These trials play a crucial role in establishing baseline data and understanding disease prevention, offering a valuable way for individuals to contribute to medical science without having a particular health concern.

Eligibility for trials varies, and the new study this month specifically includes older adults, ensuring that senior populations have ample opportunity to contribute to medical science. No new trials this month are exclusively for children, or female-only or male-only participants, indicating a broad demographic focus for the latest research.

As we move through May, the focus will likely remain on the critical enrollment deadlines for the 26 trials closing soon, while the newly opened study on tracheostomy care begins its recruitment phase. Delaware continues to be an active participant in clinical research, offering diverse opportunities for its residents to contribute to medical advancements.